Sun Pharma’s specialty portfolio, Organon deal to drive growth
Economic Times reported this story. We're following it; read the full report below.
More in Business
- Reliance Industries eyes growth boost from O2C, retail and Jio businesses
- Oil Prices No Longer Follow Headlines
- Macro headwinds cloud outlook for Indian equities in November
- Foreign selling of Indian government securities halves in October
- Supreme Court upholds order for I-T to reassess ex-CJI's sons' income
- Oil prices slip more than 1 per cent as Iran war talks continue